Article: OPTISCAN IMAGING: Optiscan enters US trials.

M2 PRESSWIRE-17 November 1999-OPTISCAN IMAGING: Optiscan enters US trials (C)1994-99 M2 COMMUNICATIONS LTD

RDATE:171199

Optiscan Imaging Limited (ASX: OIL), in which Circadian Technologies Limited (ASX: CIR) owns a 15% interest, today announced the successful installation of its unique optical fibre and laser technology equipment at the prestigious US medical imaging and microscopy centre, the Centre for Biologic Imaging at the University of Pittsburgh.

The installation is a significant step in Optiscan's aim to gain US regulatory approval by September next year.

"Optiscan's instrument is truly visionary," said Professor Simon ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!